Top compounds associated with response to RGS17


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC -0.11 0.006
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.089 0.007
mRNA MK-2206 GDSC1000 pan-cancer AAC -0.11 0.007
mRNA ML239 CTRPv2 pan-cancer AAC 0.099 0.008
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.14 0.01
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.091 0.01
Download CSV